1. Astaxov Yu.S., Shadrichev F.E., Lisochkina A.B. Diabetic retinopathy // Clinical guidelines. Ophthalmology / Eds. L.K. Moshetov, A.P. Nesterov, E.A. Egorov. Мoscow: GEOTAR-Media, 2006. 139–163. (in Russian)
2. Astaxov Yu.S., Shadrichev F.E., Lisochkina A.B. Diabetic retinopathy // Klinicheskaya oftalmologiya. 2004. 5. (2). 85–92. (in Russian)
3. Balabolkin M.I., Kreminskaya V.M., Klebanova E.M. Role of endothelial dysfunction and oxida-tive stress in the mechanisms of angiopathy in type 2 diabetes // Kardiologiya. 2004. (7). 90–97. (in Russian)
4. Gadjieva A. M. Medico-social aspects of disability due to eye pathology in diabetes: abstract of thesis …candidate of medical sciences. Moscow, 1993. (in Russian)
5. Didenko V.A., Simonov D.V. Communication insulin concentration in the blood with the renin-angiotensin-aldosterone system, and the clinical picture of hypertension // Terapevticheskiy arkhiv. 1999. (1). 26–31. (in Russian)
6. Didenko V.A. Pathogenesis, clinical course and treatment of hypertension associated with metabolic syndrome: abstract of thesis…doctor of medical sciences. Moscow, 2001. (in Russian)
7. Zimin Yu.V. Origin, diagnostic and clinical significance of the concept of insulin resistance syndrome or metabolic syndrome X // Kardiologiya. 1998. (6). 71–81. (in Russian)
8. Maltsev E.B., Rodin S.S., Chernyaeva S.N., Maxmud M.R. Diabetic retinopathy: mechanisms of development // Oftalmologicheskiy zhurnal. 2003. (2). 82–88. (in Russian)
9. Polivoda S.N. Von Willebrand factor as a marker of endothelial dysfunction in patients with diseases of the cardiovascular system // Ukrainskiy revmatologicheskiy zhurnal. 2000. (1). 13–17. (in Russian)
10. Preobrajenskii D.V. Fosinopril is the first representative of a new generation of angiotensin convert-ing enzyme inhibitors // Kardiologiya. 2000. (5). 75–82. (in Russian)
11. Preobrajenskii D.V. Successes and failures in the development of new approaches to drug therapy of chronic heart failure // Kardiologya. 2000. (4). 67–76. (in Russian)
12. Suntsov Yu.I., Kudryakova S.V., Bolotskaya L.L. Meaning of the State Register of diabetics in the development of the diabetes service // Sakharnyi diabet. 2002. (1). 28–31. (in Russian)
13. Chazova I.E. The use of ACE inhibitors for treatment of hypertension // Russkii meditsinskii jurnal. 2000. (15–16). 610–613. (in Russian)
14. Shadrichev F.E. Diabetic retinopathy // Sovremennaya optometriya. 2008. (4). 36–42. (in Russian)
15. Dzau V.J., Gibbons G.H., Pratt R.E. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia // Hypertension. 1991. 18 (4). 100–105.
16. Klein R., Klein B., Moss S. et al. The Wisconsic epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes // Ophthalmology. 1998. 105 (10). 1801–1815.
17. Lithell H.O. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism // Diabetes Care. 1991. 14. (3). 203–209.
18. Mahtab H., Kibriya M.G., Mahtab F.U. Microvascular complications in Bangladeshi type-2 diabetic individuals: Birdem Diabetes Care and Complication Study // Diabetologia. 2001. 44. (1). 285.
19. Stratton I.M., Adler A.I., Neil A.W. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study // Br. Med. J. 2000. 321. 405–412.
20. Thomann U., Buchi E.R., Suppiger M. et al. Age-dependent phenotypic expression of a pattern dystrophy of the retina // Eur. J. Ophthalmol. 1995. (5). 107–112.
21. Turner R.C., Millns H., Neil H.A.W. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS 23) // Br. Med. J. 1998. 316. 823–828.
22. UK Prospective Diabetes Study: UKPDS VIII. Study design, progress and performance // Diabetologia. 1991. 34. (12). 877–890.
23. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee // J. Hypertens. 1999. 17. 151–183.
24. Zicchelli P. Calcium channel blockers in diabetic nephropathy is there life after the ABCD trial Nephrol // Dial. Transplant. 1998. 13. 1930–1932.